Andrew S. Davis - Jan 3, 2023 Form 4 Insider Report for Silk Road Medical Inc (SILK)

Role
Chief Commercial Officer
Signature
/s/Mhairi Jones, by power of attorney
Stock symbol
SILK
Transactions as of
Jan 3, 2023
Transactions value $
-$341,287
Form type
4
Date filed
1/4/2023, 07:03 PM
Previous filing
Dec 2, 2022
Next filing
Feb 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILK Common Stock Options Exercise $8.28K +5.18K +5.27% $1.60* 103K Jan 3, 2023 Direct F1
transaction SILK Common Stock Sale -$274K -5.18K -5.01% $52.87 98.2K Jan 3, 2023 Direct F1
transaction SILK Common Stock Options Exercise $7.46K +1.58K +1.61% $4.73 99.8K Jan 3, 2023 Direct F1
transaction SILK Common Stock Sale -$83.4K -1.58K -1.58% $52.87 98.2K Jan 3, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SILK Option (right to buy) Options Exercise $0 -5.18K -19.02% $0.00 22K Jan 3, 2023 Common Stock 5.18K $1.60 Direct F1, F2
transaction SILK Option (right to buy) Options Exercise $0 -1.58K -2.5% $0.00 61.6K Jan 3, 2023 Common Stock 1.58K $4.73 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on May 20, 2022.
F2 All of the shares subject to this option are fully vested and exercisable as of the date hereof.